发明名称 Novel compounds having selective inhibiting effect at GSK3
摘要 Disclosed is a compound having formula I wherein: Z is N; Y is CONR5, NR5CO, SO2NR5, NR5CH2, NR5CONR5, C1-6alkylene, CH2CO, COCH2, CH=CH, OCH2 or CH2O; X is CH or N; P is phenyl or a 6 membered heteroaromatic ring containing one or more heteroatoms independently selected from N, O or S and said phenyl ring or heteroaromatic ring may optionally be fused with a 5 or 6 membered saturated, partially saturated or unsaturated ring containing one or more atoms selected from C, N, O or S; Q is phenyl or a 5 or 6 membered heteroaromatic ring containing one or more nitrogen atoms and said phenyl ring or heteroaromatic ring may optionally be fused with a 5 or 6 membered saturated, partially saturated or unsaturated ring containing one or more atoms selected from C, N, O or S; R is C1-6alkylNR1-R11 or C1-6alkylazetidine which azetidine ring may be optionally substituted by A; and the remainder of the substituents are as described in the specification. Also disclosed is the use of the above compound in the manufacture of a medicament for the prevention and/or treatment of diseases or disorders of the nervous system or for hyperglycaemia or for contraception or for baldness.
申请公布号 NZ540449(A) 申请公布日期 2008.02.29
申请号 NZ20030540449 申请日期 2003.12.15
申请人 ASTRAZENECA AB 发明人 BERG, STEFAN;HELLBERG, SVEN;SODERMAN, PETER
分类号 A61P3/10;A61P5/48;A61P15/18;A61P17/14;A61P25/00;C07D401/12;(IPC1-7):C07D401/12;C07D401/14;A61K31/497 主分类号 A61P3/10
代理机构 代理人
主权项
地址